Literature DB >> 16401151

Clinical predictors of drug nonresponse in obsessive-compulsive disorder.

Chandrashekhar N Shetti1, Y C Janardhan Reddy, Thennarasu Kandavel, Kartik Kashyap, Srinivas Singisetti, Avinash S Hiremath, Mulia Umar-Faruq Siddequehusen, Samar Raghunandanan.   

Abstract

OBJECTIVE: Obsessive-compulsive disorder (OCD) is often a chronic and disabling illness with high comorbidity. Serotonin reuptake inhibitors (SRIs) are effective in treating OCD. However, 40% to 60% of patients with OCD do not respond adequately to SRIs. This study aims to identify the clinical predictors of nonresponse to SRIs in OCD by comparing SRI responders and nonresponders.
METHOD: 122 subjects with a diagnosis of DSM-IV OCD of at least 1 year's duration and with treatment history of adequate trials with at least 2 SRIs were recruited from December 2002 to March 2004. Of these, 67 were SRI responders and 55 were SRI nonresponders; they were compared on various clinical parameters. Nonresponse was defined as a score of >/=3 on the Clinical Global Impressions-Improvement sub-scale (CGI-I) after at least 2 adequate trials with SRIs. Response was defined as a score of 1 or 2 on the CGI-I.
RESULTS: In regression analysis, baseline severity of OCD (p = .049), comorbid major depressive disorder (p = .005), presence of sexual obsessions (p = .002), and washing (p = .008) and miscellaneous compulsions (p = .013) were identified as predictors of nonresponse to SRIs. Early age at onset showed a trend toward prediction of nonresponse (p = .056). In the univariate analysis, mixed OCD (p = .001) and poor insight (p = .023) were associated with nonresponse.
CONCLUSION: This study has identified clinical predictors of nonresponse to SRIs. These predictors may have to be taken into consideration and assessed carefully when SRIs are prescribed to treat OCD. Future studies should aim at identifying treatment modalities that are effective in SRI nonresponders.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16401151     DOI: 10.4088/jcp.v66n1204

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  21 in total

1.  Understudied clinical dimensions in pediatric obsessive compulsive disorder.

Authors:  Adam B Lewin; Nicole Caporino; Tanya K Murphy; Gary R Geffken; Eric A Storch
Journal:  Child Psychiatry Hum Dev       Date:  2010-12

2.  Paroxetine treatment of compulsive hoarding.

Authors:  Sanjaya Saxena; Arthur L Brody; Karron M Maidment; Lewis R Baxter
Journal:  J Psychiatr Res       Date:  2006-06-21       Impact factor: 4.791

Review 3.  Excluding the typical patient: thirty years of pharmacotherapy efficacy trials for obsessive-compulsive disorder.

Authors:  Brian L Odlaug; Eric Weinhandl; Maria C Mancebo; Erik L Mortensen; Jane L Eisen; Steven A Rasmussen; Liana R N Schreiber; Jon E Grant
Journal:  Ann Clin Psychiatry       Date:  2014-02       Impact factor: 1.567

Review 4.  Obsessive-compulsive disorder: a review of the diagnostic criteria and possible subtypes and dimensional specifiers for DSM-V.

Authors:  James F Leckman; Damiaan Denys; H Blair Simpson; David Mataix-Cols; Eric Hollander; Sanjaya Saxena; Euripedes C Miguel; Scott L Rauch; Wayne K Goodman; Katharine A Phillips; Dan J Stein
Journal:  Depress Anxiety       Date:  2010-06       Impact factor: 6.505

5.  Intensive residential treatment for severe obsessive-compulsive disorder: characterizing treatment course and predictors of response.

Authors:  Brian P Brennan; Catherine Lee; Jason A Elias; Jesse M Crosby; Brittany M Mathes; Marie-Christine Andre; Christina M Gironda; Harrison G Pope; Michael A Jenike; Garrett M Fitzmaurice; James I Hudson
Journal:  J Psychiatr Res       Date:  2014-05-23       Impact factor: 4.791

6.  Obsessive-compulsive disorder for ICD-11: proposed changes to the diagnostic guidelines and specifiers.

Authors:  Helen Blair Simpson; Y C Janardhan Reddy
Journal:  Braz J Psychiatry       Date:  2014       Impact factor: 2.697

7.  Are trauma and dissociation related to treatment resistance in patients with obsessive-compulsive disorder?

Authors:  Umit B Semiz; Leman Inanc; Cigdem H Bezgin
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-11-09       Impact factor: 4.328

8.  A 5-year course of predominantly obsessive vs. mixed subtypes of obsessive-compulsive disorder.

Authors:  S B Math; Jaideep Thoduguli; Y C Janardhan Reddy; P N Manoj; A Zutshi; R P Rajkumar; A M Adarsh
Journal:  Indian J Psychiatry       Date:  2007-10       Impact factor: 1.759

Review 9.  Recent advances in compulsive hoarding.

Authors:  Sanjaya Saxena
Journal:  Curr Psychiatry Rep       Date:  2008-08       Impact factor: 5.285

10.  Venlafaxine extended-release treatment of hoarding disorder.

Authors:  Sanjaya Saxena; Jennifer Sumner
Journal:  Int Clin Psychopharmacol       Date:  2014-09       Impact factor: 1.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.